WO2015139355A1 - 一种人体可吸收的耐蚀高强韧锌镁合金植入材料 - Google Patents
一种人体可吸收的耐蚀高强韧锌镁合金植入材料 Download PDFInfo
- Publication number
- WO2015139355A1 WO2015139355A1 PCT/CN2014/076275 CN2014076275W WO2015139355A1 WO 2015139355 A1 WO2015139355 A1 WO 2015139355A1 CN 2014076275 W CN2014076275 W CN 2014076275W WO 2015139355 A1 WO2015139355 A1 WO 2015139355A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- human body
- absorbable
- implant material
- magnesium alloy
- alloy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C18/00—Alloys based on zinc
Definitions
- the invention relates to a corrosion-resistant high-strength tough zinc-magnesium alloy implant material which can be completely degraded, and belongs to the technical field of medical materials.
- An vascular stent is an implantable mesh-like instrument for the treatment of vascular diseases such as coronary heart disease, with a length of about 8 to 23 mm and a diameter of about 2.5. ⁇ 5 mm.
- Current mainstream drug-eluting stents Drug Eluting Stent, DES
- the expandable cobalt-chromium mesh provides mechanical support for the stenotic vessels, and the drug coating on the surface of the stent can release the drug continuously for about one month, inhibiting the growth of smooth muscle and lymphocytes, and reducing the inflammatory response and immune response.
- Chinese patients have not understood the stent product because the incidence of coronary heart disease in China has been extremely low in the past.
- Conventional vascular stents are generally made of non-absorbable metal.
- the preparation technique of the stent is divided into two steps. First, the metal ingot is prepared into a tube by extrusion molding, and then the tube is precisely processed into a mesh stent by laser cutting technology.
- the disadvantage is that the metal is not degradable and cannot be taken out, and it is easy to cause late thrombus in the blood vessel.
- the laser cutting technique has low efficiency and high cost.
- a large number of clinical cases have proven that traditional stents are very effective in reducing the rate of stenosis reconstruction, but patients are implanted with such stents.
- the clinically frequent late thrombosis problem is the technical bottleneck that traditional stents are difficult to break through.
- the fundamental reason is that The material used in the DES stent cannot be absorbed by the body and can only remain permanently in the blood vessels of the lesion.
- the diseased blood vessels only need 1 to 3 months of mechanical support to reconstruct the vascular function, 3 After a month, the blood vessels have basically recovered their functions, and the stents that are retained in the blood vessels may cause numerous side effects to the patient.
- bone nails and bone plates are commonly used medical implants for fixation of fractures and ligament injuries.
- the fractures near the joints and extending into the joints are especially fixed with bone nails and bone plates.
- the ageing of contemporary society is severe, and patients with osteoporosis are increasing year by year.
- Accidents such as car accidents or falls often cause comminuted fractures.
- Athletes may also have fractures or ligament tears during intense confrontational activities.
- magnesium alloy is the most in-depth research material in recent years. The material can be safely absorbed by the human body, its strength and toughness are much higher than that of the polymer, and the elastic modulus is closer to human bone.
- magnesium alloys have very poor corrosion resistance and are quickly degraded and absorbed in the human body, failing to provide sufficient mechanical support time (service period).
- the present invention provides a zinc-magnesium alloy implant material that can be absorbed and degraded by the human body, and can be used to make an absorbable medical implant, particularly a blood vessel stent, a bone nail or a bone plate.
- the corrosion-resistant high-strength tough zinc-magnesium alloy implant material of the invention can realize three technical indexes: the human body can be safely absorbed, the appropriate mechanical strength and sufficient mechanical support time.
- the absorbable stent made of the alloy material of the invention can effectively restore the normal function of the blood vessel while effectively treating the coronary heart disease, which is impossible for the conventional metal stent.
- the blood vessels of patients treated with absorbable stents may eventually have the ability to move, flex and beat, just like untreated blood vessels.
- the absorbable bone nail and the bone plate made of the alloy material of the invention can match the regenerative healing of the bone tissue, and the mechanical strength matches the human bone tissue, no stress shielding occurs, and no fracture accident occurs.
- the human body absorbable corrosion-resistant high-strength tough zinc-magnesium alloy implant material has a composition and a weight percentage of: Zn 96 ⁇ 99.998 wt%, Mg 0.002 to 4 wt%.
- the present invention strictly controls the content of impurities such as Fe, Al, Mn: Zn
- impurities such as Fe, Al, Mn: Zn
- the purity is greater than or equal to 99.95%, preferably greater than or equal to 99.999%; the purity of Mg is greater than or equal to 99.9%, preferably greater than or equal to 99.99%; except for Zn, Mg
- the total amount of inclusion elements other than is not more than 0.5%, preferably not more than 0.01%.
- the alloy material prepared by the present invention described above can be prepared into an absorbable medical implant using methods conventional in the art.
- the absorbable medical implant is preferably a vascular stent and an orthopedic implant (such as a nail or a bone plate).
- Corrosion resistance is much higher than that of magnesium alloy, and the degradation rate is greatly reduced, which can provide longer mechanical support and avoid premature failure of implants such as vascular stents and bone nails.
- the alloy material obtained has a zinc content of 99.5 wt% and a magnesium content of 0.5 wt%.
- the other steps are the same as in the first embodiment.
- the alloy material obtained was zinc-containing 98 wt% and magnesium 2 wt%.
- the other steps are the same as in the first embodiment.
- the body fluid immersion test was simulated by the alloy materials prepared in Examples 1 to 3.
- the in vitro degradation mechanism and degradation performance of zinc-magnesium alloy were studied according to the ASTM-G31-72 standard test method.
- the 37-degree Celsius simulated human body fluid simulates the human body fluid environment.
- the degradation rate of zinc-magnesium alloy is slow and controllable.
- Simulated human body fluid immersion test proves that the degradation rate of zinc-magnesium alloy is much lower than that of pure magnesium and magnesium alloy. WE43.
- the surface of the zinc-magnesium alloy forms a low-solubility protective layer, so the degradation rate is much lower than that of the magnesium alloy, and the minimum is only 0.14 mm / year, which can ensure that the vascular stent provides the blood vessel for the lesion. More than a month of radial support, fixation and bone plate mechanical support time of at least half a year.
- the slow, uniform degradation process allows the blood vessels to gradually regenerate and eventually regain expansion and pulsation, just like healthy blood vessels.
- This embodiment is based on ASTM-E8-04
- the tensile strength of the zinc-magnesium alloy bar was evaluated by the test standard. It was found that the elastic modulus of the zinc-magnesium alloy is about 80 GPa, the tensile strength is at least 220 MPa, and the highest is 340 MPa. . The highest strength zinc-magnesium alloy has an elongation of 11%, and the lowest strength zinc-magnesium alloy has an elongation of 29%. That is to say, the strength of zinc-magnesium alloy is inversely proportional to the toughness. This shows that the strength and toughness of zinc-magnesium alloy can be adjusted to meet the requirements of different stent patterns and orthopedic implant structure design. The study found that the elastic modulus of human cortical bone is 3 ⁇ 20GPa, the yield strength is 35 ⁇ 280MPa, the alloy prepared by the invention has very good matching with the mechanical properties of the human cortical bone.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
序号 | 实验材料 | 降解速度(毫米 / 年) |
1 | 实施例 1 | 0.19 |
2 | 实施例 2 | 0.14 |
3 | 实施例 3 | 0.27 |
4 | 纯镁 | 3.53 |
5 | WE43 镁合金 | 3.89 |
Claims (9)
- 一种人体可吸收的耐蚀高强韧锌镁合金植入材料,其特征在于所述合金材料包括:Zn 96~99.998wt%, Mg 0.002~4wt%。
- 如权利要求1所述的人体可吸收的耐蚀高强韧锌镁合金植入材料,其特征在于所述合金材料包括:Zn 97~99.995wt%, Mg 0.005~3wt%。
- 如权利要求1或2所述的人体可吸收的耐蚀高强韧锌镁合金植入材料,其特征在于:Zn的纯净度大于等于99.95%。
- 如权利要求3所述的人体可吸收的耐蚀高强韧锌镁合金植入材料,其特征在于:Zn的纯净度大于等于99.999%。
- 如权利要求1或2所述的人体可吸收的耐蚀高强韧锌镁合金植入材料,其特征在于:Mg的纯净度大于等于99.9%。
- 如权利要求5所述的人体可吸收的耐蚀高强韧锌镁合金植入材料,其特征在于:Mg的纯净度大于等于99.99%。
- 如权利要求1或2所述的人体可吸收的耐蚀高强韧锌镁合金植入材料,其特征在于:除Zn、Mg以外的夹杂元素总量小于0.5%。
- 如权利要求1或2所述的合金材料用于制备可吸收性医疗植入体的用途。
- 如权利要求8所述的用途,其特征在于:所述可吸收性医疗植入体为血管内支架、骨科植入体。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/126,728 US20170035942A1 (en) | 2014-03-19 | 2014-04-25 | Corrosion resistant zn-mg alloy implant material of high strength and toughness and absorbable by human body |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410101607.9A CN104587532A (zh) | 2014-03-19 | 2014-03-19 | 一种人体可吸收的耐蚀高强韧锌镁合金植入材料 |
CN201410101607.9 | 2014-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015139355A1 true WO2015139355A1 (zh) | 2015-09-24 |
Family
ID=53113799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/076275 WO2015139355A1 (zh) | 2014-03-19 | 2014-04-25 | 一种人体可吸收的耐蚀高强韧锌镁合金植入材料 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20170035942A1 (zh) |
CN (1) | CN104587532A (zh) |
WO (1) | WO2015139355A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018079923A1 (ko) * | 2016-10-31 | 2018-05-03 | 한국과학기술연구원 | 생체분해 마그네슘 합금 및 그 제조방법 |
EP4079341A3 (en) * | 2016-03-10 | 2022-11-23 | Shandong Rientech Medical Technology Co., Ltd. | Degradable zinc base alloy implant material and preparation method and use thereof |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018082726A (ja) * | 2015-03-26 | 2018-05-31 | テルモ株式会社 | 亜鉛系合金からなる医療用インプラント、およびその製造方法 |
CN106467942B (zh) * | 2015-08-19 | 2018-04-17 | 上海交通大学 | 生物可降解的医用锌铜合金及其制备方法和用途 |
CN106702212A (zh) * | 2015-11-16 | 2017-05-24 | 上海交通大学 | 医用可降解Zn-Cu-X合金材料及其制备方法 |
CN106974718A (zh) * | 2016-01-15 | 2017-07-25 | 西安爱德万思医疗科技有限公司 | 一种接骨螺钉 |
CN105925848B (zh) * | 2016-06-28 | 2017-07-11 | 东北大学 | 一种生物医用可降解锌合金内植入材料及其板材制备方法 |
CN107855528B (zh) * | 2017-10-31 | 2019-10-08 | 太原理工大学 | 一种多孔锌镁合金/羟基磷灰石复合材料的制备方法 |
CN108577922A (zh) * | 2018-02-26 | 2018-09-28 | 天津理工大学 | 一种可降解锌合金腹腔镜止血夹及其制备方法 |
CN108315583B (zh) * | 2018-03-23 | 2021-09-28 | 北京大学 | 一种Zn-Li-Mn系锌合金及其制备方法与应用 |
CN112426570A (zh) * | 2019-08-26 | 2021-03-02 | 上海交通大学 | 体内可降解高强韧医用Zn-Cu-Ag-Zr合金材料 |
CN111195374B (zh) * | 2020-01-16 | 2021-10-26 | 郑州大学第一附属医院 | 一种具有骨诱导活性的医用可降解镁-锌-镁复合棒材及其制备方法 |
CN111304495B (zh) * | 2020-03-12 | 2021-06-01 | 东南大学 | 一种医用锌合金支架及其生产方法 |
CN112899527B (zh) * | 2021-01-20 | 2022-04-08 | 湖南华锐科技集团股份有限公司 | 一种可降解锌合金棒材及其制备方法 |
CN113230457B (zh) * | 2021-05-14 | 2022-07-05 | 太原理工大学 | 一种用于骨修复的可降解多孔锌基复合材料及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2222157A (en) * | 1939-10-02 | 1940-11-19 | Atlantic Zinc Works Inc | Alloy |
US3320040A (en) * | 1963-08-01 | 1967-05-16 | American Smelting Refining | Galvanized ferrous article |
US4166153A (en) * | 1977-04-02 | 1979-08-28 | Vereinigte Deutsche Metallwerke Aktiengesellschaft | Low-alloy zinc material and coin-products made thereof |
CN101288776A (zh) * | 2007-04-18 | 2008-10-22 | 中国科学院金属研究所 | 医用高强韧耐蚀镁合金 |
CN101629260A (zh) * | 2008-07-18 | 2010-01-20 | 中国科学院金属研究所 | 医用可吸收Mg-Zn-Mn-Ca镁合金 |
WO2010082811A1 (en) * | 2009-01-15 | 2010-07-22 | Kai Holdings Sdn Bhd | A metal alloy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004089580A (ja) * | 2002-09-03 | 2004-03-25 | Kozo Nakamura | 生体材料部材 |
CN102727937B (zh) * | 2012-06-28 | 2014-03-26 | 哈尔滨工程大学 | 可生物降解锌或锌合金与多孔双相磷酸钙复合材料及其制法 |
-
2014
- 2014-03-19 CN CN201410101607.9A patent/CN104587532A/zh active Pending
- 2014-04-25 WO PCT/CN2014/076275 patent/WO2015139355A1/zh active Application Filing
- 2014-04-25 US US15/126,728 patent/US20170035942A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2222157A (en) * | 1939-10-02 | 1940-11-19 | Atlantic Zinc Works Inc | Alloy |
US3320040A (en) * | 1963-08-01 | 1967-05-16 | American Smelting Refining | Galvanized ferrous article |
US4166153A (en) * | 1977-04-02 | 1979-08-28 | Vereinigte Deutsche Metallwerke Aktiengesellschaft | Low-alloy zinc material and coin-products made thereof |
CN101288776A (zh) * | 2007-04-18 | 2008-10-22 | 中国科学院金属研究所 | 医用高强韧耐蚀镁合金 |
CN101629260A (zh) * | 2008-07-18 | 2010-01-20 | 中国科学院金属研究所 | 医用可吸收Mg-Zn-Mn-Ca镁合金 |
WO2010082811A1 (en) * | 2009-01-15 | 2010-07-22 | Kai Holdings Sdn Bhd | A metal alloy |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4079341A3 (en) * | 2016-03-10 | 2022-11-23 | Shandong Rientech Medical Technology Co., Ltd. | Degradable zinc base alloy implant material and preparation method and use thereof |
WO2018079923A1 (ko) * | 2016-10-31 | 2018-05-03 | 한국과학기술연구원 | 생체분해 마그네슘 합금 및 그 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
CN104587532A (zh) | 2015-05-06 |
US20170035942A1 (en) | 2017-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015139355A1 (zh) | 一种人体可吸收的耐蚀高强韧锌镁合金植入材料 | |
WO2015096271A1 (zh) | 一种人体可吸收的耐蚀高强韧锌合金植入材料 | |
Wang et al. | Research progress of biodegradable magnesium-based biomedical materials: A review | |
WO2017028646A1 (zh) | 生物可降解的医用锌铜合金及其制备方法和用途 | |
JP6786214B2 (ja) | マグネシウム合金、その製造方法およびその使用 | |
CN101015711B (zh) | 一种可体液降解的医用植入体及其制备方法 | |
CN107541631B (zh) | 一种生物医用可降解耐蚀高强韧镁合金及其制备方法 | |
CN103614601B (zh) | 生物体内可控降解Mg-Ag-Zn-Mn抑菌镁合金植入材料及其制备 | |
EP2213314B1 (en) | Implant with a base body of a biocorrodible magnesium alloy | |
WO2011160534A1 (zh) | 体内可降解的镁合金血管支架材料及其制造方法 | |
WO2017084363A1 (zh) | 医用可降解Zn-Cu-X合金材料及其制备方法 | |
WO2013052791A2 (en) | Biodegradable metal alloys | |
WO2017124613A1 (zh) | 一种全降解镁合金及其制备方法 | |
CN108315583B (zh) | 一种Zn-Li-Mn系锌合金及其制备方法与应用 | |
CN109602960B (zh) | 一种具备超塑性的医用锌合金棒材制备方法 | |
CN101081311A (zh) | 一种生物医用β-钛合金材料 | |
CN102258806B (zh) | 一种可降解镁基骨科植入生物医用材料及制备方法 | |
CN115181879A (zh) | 一种可降解镁合金原位复合吻合钉及其制备方法 | |
CN106282664A (zh) | 生物可降解医用锌锂二元合金材料及其制备方法与应用 | |
CN110694121A (zh) | 一种体内可降解镁合金吻合钉及其制备方法 | |
CN107198796B (zh) | 一种生物医用Zn-Mn-Cu系锌合金及其制备方法 | |
CN108165782A (zh) | 一种医用锌基合金带材及其制备方法 | |
CN109280827A (zh) | 吻合钉及其制备方法和应用 | |
CN109252117B (zh) | 一种可降解骨植入镁合金及其制备方法 | |
US20190003016A1 (en) | Alloy material and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14886262 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15126728 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 25-01-2017) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14886262 Country of ref document: EP Kind code of ref document: A1 |